Previous studies showed that quercetin and kaempferol acted as NR4A1 antagonists in Rh30 rhabdomyosarcoma cells [33] and decreased NR4A1-dependent transactivation in this cell line. This evidence concerns the gene NR4A1 and rhabdomyosarcoma.